Ranjeet Ajmani: Southeast Asia – 25% of The Global Population Contributes Less than 2% of The Global Plasma Supply
Ranjeet Ajmani, Chief Executive Officer- Asia at Aegros, shared on LinkedIn:
”It will be an honor to share experiences and insights at the Business Forum (October, 16, 2025) of the Plasma Protein Therapeutics Association (PPTA), Virginia, USA
Southeast Asia (SEA), home to over 2 billion people—about 25% of the global population—contributes less than 2% of the global plasma supply.
This disparity is clearly reflected in patient care, particularly in the availability, accessibility, and affordability of Plasma-Derived Medicinal Products (PDMPs).
The situation is further exacerbated by limited public healthcare expenditure, inadequate health policies, and regulatory challenges.
As a result, a vast majority of patients in developing countries remain undiagnosed.
Many live with serious, yet treatable, conditions—often in silence, suffering without support, and sadly passing away without ever receiving the care they need.
These stories are not just statistics—they are deeply human, and often heart-wrenching.
We must ask ourselves: Can we do more for our fellow citizens?
The answer must be yes.
By fostering collaboration across governments, regulators, industry, and patient advocacy groups, and by reimagining policies and infrastructure, we can build a more equitable future—one in which no one is left behind simply because of where they were born.”

Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis
